Rapid Motion-Robust and Easy-to-Use Dynamic Contrast-Enhanced MRI for Liver Perfusion Quantification (Non-treatment cohort)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Hepatocellular Carcinom
  • Age: Between 18 - 100 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
      Patients:
    1. Hepatocellular carcinoma (HCC) patients scheduled for stand-of-care MRI exams.
    2. Competent and willing to provide verbal informed consent.
    3. At least one HCC lesion > 1.5cm.
      Healthy controls:
    1. Competent and willing to sign informed consent.

You may not be eligible for this study if the following are true:

    1. Significant medical or neurological illness.
    2. Implanted metal devices, tattoos larger than 1 cm in diameter (risk during MRI scanning) or tattoos with metallic ink.
    3. Claustrophobia (patients who are afraid of stating in small closed space).
    4. Pregnancy.
    5. Breast feeding.
    6. Contraindication to contrast injection (e.g., severe kidney disease with glomerular filtration rate).



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.